Steinert, Elizabeth M. https://orcid.org/0000-0002-6947-2271
Furtado Bruza, Beatriz https://orcid.org/0009-0009-1675-189X
Danchine, Veronika D. https://orcid.org/0009-0002-7195-3899
Grant, Rogan A.
Vasan, Karthik
Kharel, Arjun https://orcid.org/0000-0002-4203-5469
Zhang, Yuqi
Cui, Weiguo https://orcid.org/0000-0003-1562-9218
Szibor, Marten https://orcid.org/0000-0003-4029-160X
Weinberg, Samuel E. https://orcid.org/0000-0002-9532-7051
Chandel, Navdeep S. https://orcid.org/0000-0001-7208-3886
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R01AI148190, 5P01HL154998, F30CA250236)
Cancer Research Institute (Cancer Research Institute Fellow)
Schmidt Science Fellows, in partnership with the Rhodes Trust.
Article History
Received: 7 August 2024
Accepted: 23 May 2025
First Online: 16 July 2025
Competing interests
: M.S. is a shareholder in a start-up company founded to develop therapeutics based on AOX. The other authors declare no competing interests.